Clinical Trials Browser

INDUSTRY × tislelizumab × NET × Clear all

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT05167071 2025-04-27

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Phase 1 Active not recruiting

53 enrolled

EndocrineNET

Neuroendocrine Tumors

Clinical Trials

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study